KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 93 filers reported holding KALVISTA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $145,000 | +48.0% | 10,000 | 0.0% | 0.03% | +36.0% |
Q2 2022 | $98,000 | -66.7% | 10,000 | -50.0% | 0.02% | -32.4% |
Q1 2022 | $294,000 | +122.7% | 20,000 | +100.0% | 0.04% | +94.7% |
Q4 2021 | $132,000 | -40.8% | 10,000 | -21.6% | 0.02% | -62.7% |
Q3 2021 | $223,000 | -13.2% | 12,754 | +27.5% | 0.05% | +104.0% |
Q1 2021 | $257,000 | – | 10,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 589,270 | $8,686,000 | 5.61% |
GREAT POINT PARTNERS LLC | 874,197 | $12,886,000 | 3.11% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 383,233 | $10,805,000 | 2.44% |
Frazier Life Sciences Management, L.P. | 1,572,192 | $23,174,000 | 1.98% |
TANG CAPITAL MANAGEMENT LLC | 648,269 | $9,555,000 | 1.91% |
Deep Track Capital, LP | 1,729,757 | $25,497,000 | 1.64% |
Vivo Capital, LLC | 1,533,559 | $22,605,000 | 1.56% |
Monashee Investment Management LLC | 264,111 | $3,893,000 | 1.13% |
COMMODORE CAPITAL LP | 312,553 | $4,607,000 | 1.03% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,746,300 | $25,740,000 | 0.79% |